Farmak

As someone who personally lives with allergies, I truly appreciate the importance of continued research in this field. Proud to see BIOMEDICA CRO supporting scientists with high-quality biospecimens that can help advance asthma and allergy studies worldwide 👏

🌍 For 4 days this week, Germany — a country better known for precision than indulgence — quietly transformed into a global crossroads of cannabis culture. Across the city of Berlin, three very different but surprisingly aligned gatherings took place: — Global Cannabis Network Collective — where C-suites connect (and occasionally in/exhale) — The Talman Group — a cannabis "salon" blending culture with discussions on new business models and M&A — InternationalCBC — one of the largest B2B events in the industry The more time you spend in this space, the clearer the parallels with big pharma become: -vertical integration, -relentless cost optimization, -GACP & EU-GMP compliance, -GDP logistics, -increasingly sophisticated patient segmentation, and -the eternal pursuit of added value. In other words — a highly disciplined, increasingly standardized industry. And yet, cannabis insists on keeping one foot outside the spreadsheet. Because beyond all clinical narratives and regulatory frameworks, there remains something "disarmingly human" at its core: ENJOYMENT 🙃 🌈 It’s a curious business, after all — where product-market fit can be measured not only in efficacy, but in experience ⚖️ A sector where the medicine may be serious… but doesn’t always have to feel that way... 🌿😏